Cargando…
P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429344/ http://dx.doi.org/10.1097/01.HS9.0000848048.13001.58 |
| _version_ | 1784779411218759680 |
|---|---|
| author | Taghi Khani, A. Kumar, A. Radecki, K. Lee, S. J. Sanchez Ortiz, A. Lorenson, M. Wu, X. Koff, J. Forman, S. Gu, Z. Walker, A. Swaminathan, S. |
| author_facet | Taghi Khani, A. Kumar, A. Radecki, K. Lee, S. J. Sanchez Ortiz, A. Lorenson, M. Wu, X. Koff, J. Forman, S. Gu, Z. Walker, A. Swaminathan, S. |
| author_sort | Taghi Khani, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429344 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94293442022-08-31 P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES Taghi Khani, A. Kumar, A. Radecki, K. Lee, S. J. Sanchez Ortiz, A. Lorenson, M. Wu, X. Koff, J. Forman, S. Gu, Z. Walker, A. Swaminathan, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429344/ http://dx.doi.org/10.1097/01.HS9.0000848048.13001.58 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Taghi Khani, A. Kumar, A. Radecki, K. Lee, S. J. Sanchez Ortiz, A. Lorenson, M. Wu, X. Koff, J. Forman, S. Gu, Z. Walker, A. Swaminathan, S. P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_full | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_fullStr | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_full_unstemmed | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_short | P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES |
| title_sort | p1296: suppressing synthesis of the long isoform of the prolactin receptor is a targeted strategy to treat autoimmune b-lymphoproliferative diseases and b cell malignancies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429344/ http://dx.doi.org/10.1097/01.HS9.0000848048.13001.58 |
| work_keys_str_mv | AT taghikhania p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT kumara p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT radeckik p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT leesj p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT sanchezortiza p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT lorensonm p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT wux p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT koffj p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT formans p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT guz p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT walkera p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies AT swaminathans p1296suppressingsynthesisofthelongisoformoftheprolactinreceptorisatargetedstrategytotreatautoimmuneblymphoproliferativediseasesandbcellmalignancies |